| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.055 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |